CPT 89290 PGD Biopsy Reimbursement & Policy

CPT code 89290 covers microtechnique biopsy of oocyte polar bodies or embryo blastomeres for preimplantation genetic diagnosis (PGD) involving five or fewer embryos. This laboratory-level procedure is central to assisted reproductive technology workflows that aim to identify genetic abnormalities before embryo transfer. Nationally, the code matters because PGD influences clinical decision-making in IVF, impacts laboratory resource use, and intersects with evolving payer policies on fertility and genetic services.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for CPT code 89290, typical sites of service, and the kinds of billing modifiers commonly associated with laboratory and professional components. The publication also summarizes benchmark topics relevant to payers and providers: expected service line placement, common billing practices, and where policy updates may affect coverage and documentation requirements.

This summary equips administrators, billing professionals, and clinicians with a clear reference for the clinical purpose of CPT code 89290, the payer landscape that typically influences authorization and reimbursement decisions, and the operational context in which the service is delivered. Data not available in the input is noted where applicable.

Billing Code Overview

CPT code 89290 describes a laboratory microtechnique biopsy of oocyte polar bodies or embryo blastomeres for preimplantation genetic diagnosis (PGD). The procedure involves sampling from five or fewer embryos to obtain cells for genetic testing prior to embryo transfer.

Service Type: Preimplantation genetic diagnosis (PGD) cell biopsy

Typical Site of Service: In vitro fertilization (IVF) laboratory or embryology laboratory; performed as part of assisted reproductive technology procedures

Clinical Context

A 34-year-old woman with a history of recurrent pregnancy loss secondary to a known parental balanced translocation undergoes in vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD). After oocyte retrieval and fertilization, embryology performs micromanipulation biopsy of up to five embryos' blastomeres (or oocyte polar bodies if applicable) to obtain cellular material for genetic testing. The embryology laboratory analyst uses microtechniques and a microscope to extract one or more polar bodies or blastomeres while maintaining embryo viability. Biopsied cells are sent to a genetics laboratory for analysis (e.g., karyotyping, targeted mutation testing, or comprehensive chromosome screening). Results guide embryo selection for transfer or cryopreservation. Typical sites of service include outpatient fertility clinics, ambulatory surgery centers associated with reproductive endocrinology programs, and specialized embryology laboratories within hospital-based reproductive medicine centers.

Coding Specifications

Modifier	Description	When to Use
`00`	Default (no modifier)	Use when no additional modifier applies to the service.
`22`	Increased procedural services

Taxonomy Code	Specialty	Notes
163W00000X	Reproductive Endocrinology and Infertility	Physicians who direct IVF and PGD programs; oversight of embryo biopsy procedures.
1223P0001X	Clinical Laboratory Scientist	Laboratory personnel performing micromanipulation and biopsy techniques in embryology labs.
207RG0300X	Obstetrics & Gynecology	Reproductive surgeons and OB/GYNs involved in IVF programs and oocyte retrieval coordination.
3336C0002X	Genetic Counseling	Genetic counselors who interpret PGD results and counsel patients on embryo selection implications.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N97.0`	Female infertility associated with anovulation	Common indication for IVF and potential PGD when genetic causes are a concern.
`N97.1`	Female infertility of tubal origin	Patients with tubal factor infertility may undergo IVF and PGD for genetic screening.
`N97.9`	Female infertility, unspecified	General infertility diagnosis leading to IVF and consideration of PGD.
`Z31.5`	Encounter for genetic counseling	Often accompanies PGD when couples seek genetic risk assessment and embryo testing.
`O35.8`	Maternal care for other known or suspected fetal abnormality and damage	Used when there is a known parental risk of genetic disease prompting PGD.
`Q87.1`	Chromosomal anomalies, not elsewhere classified	Parental or embryo chromosomal concerns that indicate PGD for embryo selection.
`Z31.0`	Encounter for procreative management, fertility testing	Administrative diagnosis associated with IVF cycles culminating in embryo biopsy for PGD.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`89280`	Assisted hatching, by mechanical or chemical technique, or both	Often performed on embryos in IVF cycles either before or after biopsy to facilitate implantation.
`89281`	Embryo culture, less than or equal to 3 days, with embryo evaluation	Describes laboratory culture and evaluation services that precede or follow biopsy.
`89286`	Preparation of sperm (e.g., washing, capacitation) for assisted reproductive procedures	Performed earlier in the IVF cycle to fertilize oocytes prior to embryo biopsy.
`89250`	Oocyte retrieval, aspiration of follicles for oocyte collection	Procedural step preceding embryo creation and subsequent biopsy for PGD.
`89291`	Micromanipulation for preimplantation genetic testing, more than five embryos	Related code when more than five embryos are biopsied; differentiates by embryo count.

OpenPayer

Summary & Overview

CPT 89290: PGD Biopsy of Oocyte Polar Bodies or Embryo Blastomeres